Medtech Execs On The Move, December 2015
Executive Summary
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
You may also be interested in...
House Health Subcommittee Chair Prioritizes Affordability, Innovation, Ending COVID PHE
Kentucky Republican Brett Guthrie is strong proponent of health care affordability and innovation in pharmaceuticals and medical devices. He’s also monitoring FDA’s response to drug shortages and infant formula shortages.
US Dietary Supplement Industry In 2023: Little New Expected In NDI Notification Enforcement
Chief executives of OTC drug and supplement industry trade groups discussed potential market and regulatory developments affecting their members’ businesses. HBW Insight concludes series here reporting on supplement sector’s outlook for FDA potentially resolving its protracted struggle with NDI notification requirement.
As COVID Public Health Emergency Winds Down, US FDA Employs Flexibility For Rx EUA Transitions
Biden administration sets May 11 as end date for public health emergency. CDER has said it will work with sponsors to help them gain approval of COVID therapeutics cleared under emergency use authorizations, but agency will likely not issue a formal transition framework.